Definitive Healthcare (DH) Cash & Equivalents (2020 - 2026)

Definitive Healthcare (DH) has reported Cash & Equivalents for 7 consecutive years, with $170.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 110.99% year-over-year to $170.9 million; the trailing twelve-month figure through Jun 2026 stood at $170.9 million (up 110.99% YoY), and the FY2025 full-year result was $163.6 million, up 55.28% from the prior year.
• Cash & Equivalents climbed to $170.9 million in Q2 2026 per DH's latest filing, from $157.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $229.8 million in Q1 2022 and bottomed at $77.5 million in Q3 2023.
• Historically, Cash & Equivalents has averaged $142.1 million across 5 years, with a median of $131.7 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Cash & Equivalents tumbled 66.15% in 2023, then soared 110.99% in 2026.
• Over 5 years, Cash & Equivalents stood at $146.9 million in 2022, then slipped by 10.86% to $131.0 million in 2023, then declined by 19.54% to $105.4 million in 2024, then surged by 55.28% to $163.6 million in 2025, then gained by 4.42% to $170.9 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $170.9 million, $157.6 million, and $163.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.